Thiamazole as an adjuvant to radioiodine for volume reduction of multinodular goiter

Expert Opinion on Investigational Drugs

Volumn 17, Issue 12, 2008, Pages 1781-1786

  Albino, Cláudio ^a,b   Graf, Hans ^c   Sampaio, Ana P ^a   Vigário, Adriano ^a   Paz Filho, Gilberto J ^b  

^a Núcleo Diagnóstico Maringá ^*  (Brazil)

^b Instituto de Diabetes E Endocrinologia de Maringá IDEM and Núcleo Diagnóstico   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

131I; Goiter; Radioiodine; Thiamazole; Thyroid; Uptake

Indexed keywords

IODINE 131; LEVOTHYROXINE; THIAMAZOLE; THYROID HORMONE; RADIOACTIVE IODINE;

ADD ON THERAPY; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG UPTAKE; FEMALE; GOITER; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; NODULAR GOITER; THYROID HORMONE BLOOD LEVEL; THYROID WEIGHT; THYROIDITIS; TREATMENT DURATION; TREATMENT OUTCOME; ADJUVANT THERAPY; CLINICAL TRIAL; PATHOLOGY;

AGED; FEMALE; GOITER, NODULAR; HUMANS; IODINE RADIOISOTOPES; METHIMAZOLE; RADIOTHERAPY, ADJUVANT;

EID: 58149385839     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543780802501325     Document Type: Article

References (22)

1. Agarwal G, Aggarwal V. Is total thyroidectomy the surgical procedure of choice for benign multinodular goiter? An evidence-based review. World J Surg 2008;32:1313-1324
2. Bonnema SJ, Bertelsen H, Mortensen J, et al. The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. J Clin Endocrinol Metab 1999;84:3636-3641 (Pubitemid 30645217)
3. Wesche MF, Tiel-v-Buul MM, Smits NJ, et al. Reduction in goiter size by 131I therapy in patients with non-toxic multinodular goiter. Eur J Endocrinol 1995;132:86-87
4. Medeiros-Neto G, Marui S, Knobel M. An outline concerning the potential use of recombinant human thyrotropin for improving radioiodine therapy of multinodular goiter. Endocrine 2008;33:109-117
5. Huysmans DA, Nieuwlaat WA, Erdtsieck RJ, et al. Administration of a single low dose of recombinant human thyrotropin signifi cantly enhances thyroid radioiodide uptake in nontoxic nodular goiter. J Clin Endocrinol Metab 2000;85:3592-3596 (Pubitemid 30828559)
6. Nieuwlaat WA, Hermus AR, Sivro-Prndelj F, et al. Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters. J Clin Endocrinol Metab 2001;86:5330-5336 (Pubitemid 33070255)
7. Albino CC, Mesa CO Jr, Olandoski M, et al. Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine. J Clin Endocrinol Metab 2005;90:2775-2780 (Pubitemid 40686323)
8. Bonnema SJ, Nielsen VE, Boel-Jorgensen H, et al. Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial. J Clin Endocrinol Metab 2007;92:3424-3428 (Pubitemid 47435314)
9. Cohen O, Ilany J, Hoffman C, et al. Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients. Eur J Endocrinol 2006;154:243-252 (Pubitemid 43308826)
10. Duick DS, Baskin HJ. Signifi cance of radioiodine uptake at 72 hours versus 24 hours after pretreatment with recombinant human thyrotropin for enhancement of radioiodine therapy in patients with symptomatic nontoxic or toxic multinodular goiter. Endocr Pract 2004;10:253-260
11. Nielsen VE, Bonnema SJ, Boel-Jorgensen H, et al. Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial. Arch Intern Med 2006;166:1476-1482 (Pubitemid 44125866)
12. Nieuwlaat WA, Huysmans DA, Van Den Bosch HC, et al. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J Clin Endocrinol Metab 2003;88:3121-3129 (Pubitemid 36877482)
13. Paz-Filho GJ, Mesa-Junior CO, Olandoski M, et al. Effect of 30 mCi radioiodine on multinodular goiter previously treated with recombinant human thyroid-stimulating hormone. Braz J Med Biol Res 2007;40:1661-1670
14. Silva MN, Rubio IG, Romao R, et al. Administration of a single dose of recombinant human thyrotrophin enhances the effi cacy of radioiodine treatment of large compressive multinodular goitres. Clin Endocrinol (Oxf) 2004;60:300-308 (Pubitemid 38297119)
15. Cooper DS. Antithyroid drugs. N Engl J Med 2005;352:905-917 (Pubitemid 40300299)
16. Andrade VA, Gross JL, Maia AL. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study. J Clin Endocrinol Metab 2001;86:3488-3493 (Pubitemid 32755934)
17. Bonnema SJ, Bennedbaek FN, Gram J, et al. Resumption of methimazole after 131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clinical trial. Eur J Endocrinol 2003;149:485-492 (Pubitemid 38063062)
18. Braga M, Walpert N, Burch HB, et al. The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial. Thyroid 2002;12:135-139 (Pubitemid 34213997)
19. Imseis RE, Vanmiddlesworth L, Massie JD, et al. Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism. J Clin Endocrinol Metab 1998;83:685-687 (Pubitemid 28496558)
20. Walter MA, Briel M, Christ-Crain M, et al. Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials. BMJ 2007;334:514-517 (Pubitemid 46588147)
21. Hengstmann JH, Hohn H. Pharmacokinetics of methimazole in humans. Klin Wochenschr 1985;63:1212-1217 (Pubitemid 16169744)
22. Methimazole: Drug information. In: Basow DS, editor. UpToDate. Waltham, MA, UpToDate; 2008